Combines age, sex and ECLIA measurements of AFP and PIVKA-II into a score associated with hepatocellular carcinoma.
Used alongside imaging and clinical assessment to aid detection of hepatocellular carcinoma in adults with chronic liver disease. It is not a stand-alone cancer screening test.